We have demonstrated that Hh transcription factors GLI1/2 were able to bind to the consensus sequence in the promoter of ABCC1 or ABCB2 to facilitate resistance to sorafenib, doxorubicin and cisplatin in poorly differentiated hepatoma cells. This evidence concerns the gene ABCC1 and hepatocellular carcinoma.